Ladarixin sodium

Names

[ Name ]:
Ladarixin sodium

[Synonym ]:
Methanesulfonic acid, 1,1,1-trifluoro-, 4-[(1R)-1-methyl-2-[(methylsulfonyl)amino]-2-oxoethyl]phenyl ester, sodium salt (1:1)
Sodium (1Z,2R)-N-(methylsulfonyl)-2-(4-{[(trifluoromethyl)sulfonyl]oxy}phenyl)propanimidate

Biological Activity

[Description]:

A novel allosteric, noncompetitive dual CXCR1/2 inhibitor that inhibits human polymorphonuclear leukocyte (PMN) migration to CXCL8 in vitro with IC50 of 0.7 nM; prevents PMN infiltration and tissue damage in several models of IR injury in vivo; abrogates motility and induces apoptosis in cultured cutaneous and uveal melanoma cells and xenografts; also prevents inflammation-mediated damage in MLD-STZ, prevents and reverses diabetes in NOD mice. Diabetes Phase 2 Clinical

[References]

References 1. Garau A, et al. Eur Cytokine Netw. 2006 Mar;17(1):35-41. 2. Citro A, et al. Diabetes. 2015 Apr;64(4):1329-40. 3. Kemp DM, et al. Oncotarget. 2017 Feb 28;8(9):14428-14442. 4. Bertini R, et al. Br J Pharmacol. 2012 Jan;165(2):436-54. View Related Products by Target Chemokine Receptor (CCR and CXCR) Diabetes

Chemical & Physical Properties

[ Molecular Formula ]:
C₁₁H₁₁F₃NNaO₆S₂

[ Molecular Weight ]:
397.323

[ Exact Mass ]:
396.987762

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.